Cargando…
Dalbavancin to Treat Infected Massive Endoprostheses: A Case Report and Cost Comparison Analysis
We report a case of an infected massive endoprosthetic replacement treated successfully with 2 stage surgery and off-label dalbavancin. Dalbavancin was used due to a limited number of antimicrobial options that could be administered safely in an outpatient setting and to avoid the need for daily dos...
Autores principales: | Azamgarhi, Tariq, Donaldson, James, Shah, Ashik, Warren, Simon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831803/ https://www.ncbi.nlm.nih.gov/pubmed/31700772 http://dx.doi.org/10.7150/jbji.37980 |
Ejemplares similares
-
Risk factors for recurrent infection in the surgical treatment of infected massive endoprostheses implanted for musculoskeletal tumours
por: Azamgarhi, Tariq, et al.
Publicado: (2023) -
The Use of Massive Endoprostheses for the Treatment of Bone Metastases
por: Park, D. H., et al.
Publicado: (2007) -
A case of Trueperella pyogenes causing prosthetic joint infection
por: Azamgarhi, Tariq, et al.
Publicado: (2020) -
Osteointegration of hydroxyapatite-coated collars in cemented massive endoprostheses following revision surgery
por: Davies, Benjamin, et al.
Publicado: (2021) -
1028. Dalbavancin Use in Complicated Infections and-associated Cost-Savings
por: Streifel, Amber C, et al.
Publicado: (2019)